Investing in ANI Pharmaceuticals, Inc. (ANIP)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)17.32-74
Intrinsic value (DCF)2.73-96
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

ANI Pharmaceuticals Inc. (ANIP) is a specialty pharmaceutical company that focuses on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company's products range from oral solid dose products to liquids, creams, ointments, and suppositories. ANI has a diverse portfolio of products that are sold to wholesalers, hospitals, and pharmacies across the United States. They also have an international presence, with distribution in several other countries. The company's mission is to improve the lives of patients by providing high-quality, cost-effective medications. ANI strives to maintain strong relationships with its customers, suppliers, and partners to ensure the continuous growth and success of the company. In addition to its current product line, ANI is continuously developing new products and pursuing strategic partnerships to expand its reach and increase its market share. With a strong commitment to research and development, ANI is constantly advancing its technology and investing in new opportunities for growth. Overall, ANI is a well-established and reputable company in the pharmaceutical industry, dedicated to delivering innovative and affordable healthcare solutions to patients worldwide.